The above results suggest that targeted inhibition of NRF2 or upregulation of PHKG2 both reversed the radioresistance and increased the radiosensitivity in NSCLC, the process of which is associated with ferritinophagy and mitochondrial dysfunction. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.